FDA Responds To Antidepressant Inquiry, Says All Data Properly Disclosed

Conclusions about a link between antidepressants and suicidal behavior by an FDA safety reviewer were not presented at a Feb. 2 advisory committee because they did not concur with the agency's findings, FDA said